Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cosmos Health Inc
(NQ:
COSM
)
1.140
-0.100 (-8.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
473,414
Open
1.200
Bid (Size)
1.110 (1)
Ask (Size)
1.120 (5)
Prev. Close
1.240
Today's Range
1.110 - 1.220
52wk Range
0.4677 - 2.050
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units
July 18, 2024
Via
ACCESSWIRE
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule
July 18, 2024
Via
ACCESSWIRE
Performance
YTD
-16.79%
-16.79%
1 Month
+69.11%
+69.11%
3 Month
+132.18%
+132.18%
6 Month
+12.87%
+12.87%
1 Year
-35.59%
-35.59%
More News
Read More
Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market
July 10, 2024
Via
ACCESSWIRE
Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually
July 09, 2024
Via
ACCESSWIRE
Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE
July 02, 2024
Via
ACCESSWIRE
Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months
July 02, 2024
Via
ACCESSWIRE
Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains
July 01, 2024
Via
ACCESSWIRE
Why Cosmos Health Stock Is Trading Higher Friday
June 28, 2024
Via
Benzinga
Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today?
June 28, 2024
Via
InvestorPlace
Why Is Nexalin Technology (NXL) Stock Down 35% Today?
June 28, 2024
Via
InvestorPlace
Why Is Cosmos Health (COSM) Stock Up 65% Today?
June 28, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 28, 2024
Via
InvestorPlace
Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units
June 27, 2024
Via
ACCESSWIRE
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent
June 18, 2024
Via
ACCESSWIRE
Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million
June 13, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
May 30, 2024
Via
Benzinga
Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q
May 24, 2024
Via
ACCESSWIRE
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
May 17, 2024
Via
ACCESSWIRE
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks
April 30, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
April 29, 2024
Via
Benzinga
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
April 19, 2024
Via
ACCESSWIRE
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
March 21, 2024
Via
ACCESSWIRE
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
March 19, 2024
Via
ACCESSWIRE
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
March 18, 2024
Via
ACCESSWIRE
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
February 29, 2024
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.